290 related articles for article (PubMed ID: 30529013)
1. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
2. DNA-methylation profiling distinguishes malignant melanomas from benign nevi.
Conway K; Edmiston SN; Khondker ZS; Groben PA; Zhou X; Chu H; Kuan PF; Hao H; Carson C; Berwick M; Olilla DW; Thomas NE
Pigment Cell Melanoma Res; 2011 Apr; 24(2):352-60. PubMed ID: 21375697
[TBL] [Abstract][Full Text] [Related]
3. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L; van den Hurk K; Moerkerk PTM; Goeman JJ; Beck S; Gruis NA; van den Oord JJ; Winnepenninckx VJ; van Engeland M; van Doorn R
J Invest Dermatol; 2014 Dec; 134(12):2957-2966. PubMed ID: 24999589
[TBL] [Abstract][Full Text] [Related]
4. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
5. Reduced H3K27me3 Expression Is Common in Nodular Melanomas of Childhood Associated With Congenital Melanocytic Nevi But Not in Proliferative Nodules.
Busam KJ; Shah KN; Gerami P; Sitzman T; Jungbluth AA; Kinsler V
Am J Surg Pathol; 2017 Mar; 41(3):396-404. PubMed ID: 27849631
[TBL] [Abstract][Full Text] [Related]
6. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
7. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
[TBL] [Abstract][Full Text] [Related]
8. A multi-marker assay to distinguish malignant melanomas from benign nevi.
Kashani-Sabet M; Rangel J; Torabian S; Nosrati M; Simko J; Jablons DM; Moore DH; Haqq C; Miller JR; Sagebiel RW
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6268-72. PubMed ID: 19332774
[TBL] [Abstract][Full Text] [Related]
9. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study.
Elbaum M; Kopf AW; Rabinovitz HS; Langley RG; Kamino H; Mihm MC; Sober AJ; Peck GL; Bogdan A; Gutkowicz-Krusin D; Greenebaum M; Keem S; Oliviero M; Wang S
J Am Acad Dermatol; 2001 Feb; 44(2):207-18. PubMed ID: 11174377
[TBL] [Abstract][Full Text] [Related]
10. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
12. Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis.
Alexandrescu DT; Kauffman CL; Jatkoe TA; Hartmann DP; Vener T; Wang H; Derecho C; Rajpurohit Y; Wang Y; Palma JF
J Invest Dermatol; 2010 Jul; 130(7):1887-92. PubMed ID: 20357814
[TBL] [Abstract][Full Text] [Related]
13. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy.
Jackett LA; Colebatch AJ; Rawson RV; Ferguson PM; Thompson JF; McCarthy SW; Wilmott JS; Scolyer RA
Am J Surg Pathol; 2020 Mar; 44(3):357-367. PubMed ID: 31743128
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Uchiyama R; Uhara H; Uchiyama A; Ogawa E; Takazawa Y; Ashida A; Koga H; Hayashi K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2014 Feb; 73(2):161-3. PubMed ID: 24169492
[No Abstract] [Full Text] [Related]
15. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
16. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
17. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
18. Duplex Ratio Tests as Diagnostic Biomarkers in Malignant Melanoma.
Moore DA; Saldanha G; Ehdode A; Mughal MZ; Potter L; Dyall L; Pringle JH
J Mol Diagn; 2015 Sep; 17(5):616-22. PubMed ID: 26134170
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.
Gao L; Smit MA; van den Oord JJ; Goeman JJ; Verdegaal EM; van der Burg SH; Stas M; Beck S; Gruis NA; Tensen CP; Willemze R; Peeper DS; van Doorn R
Pigment Cell Melanoma Res; 2013 Jul; 26(4):542-54. PubMed ID: 23590314
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O; Fraitag S; Hohl D
J Invest Dermatol; 2016 Dec; 136(12):2453-2461. PubMed ID: 27456754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
